Acetaminophen Pregnancy: Safe or Not? – Science Says
- Department of Health and Human Services (HHS) announced new initiatives aimed at advancing autism research, with a particular focus on the potential roles of leucovorin and acetaminophen in...
- The HHS declaration highlights a renewed interest in investigating the role of folate metabolism and leucovorin in individuals with ASD.Leucovorin is a form of folic acid sometimes used...
- The initiative will fund research to explore whether leucovorin supplementation during specific developmental windows could perhaps mitigate some ASD-related symptoms in individuals with identified genetic predispositions.
“`html
HHS Announces New Autism Initiatives, Research Focus on Leucovorin and Acetaminophen
Table of Contents
Published September 26, 2025, at 20:30
Overview
The U.S. Department of Health and Human Services (HHS) announced new initiatives aimed at advancing autism research, with a particular focus on the potential roles of leucovorin and acetaminophen in autism spectrum disorder (ASD).
Leucovorin and Folate Research
The HHS declaration highlights a renewed interest in investigating the role of folate metabolism and leucovorin in individuals with ASD.Leucovorin is a form of folic acid sometimes used to enhance the effects of chemotherapy, but its potential impact on neurodevelopment is being re-examined.Some research suggests that variations in folate metabolism genes may be more common in individuals with ASD, leading to hypotheses about potential interventions.
The initiative will fund research to explore whether leucovorin supplementation during specific developmental windows could perhaps mitigate some ASD-related symptoms in individuals with identified genetic predispositions. This research will be conducted under strict ethical guidelines and with careful monitoring of participant safety.
Acetaminophen (Tylenol) and Neurodevelopment
A important portion of the new research effort will focus on the potential link between acetaminophen (Tylenol) use during pregnancy and the risk of ASD in offspring.This area of research has gained prominence in recent years due to observational studies suggesting a possible association. Though, establishing causation remains a significant challenge.
The HHS announcement emphasizes the need for rigorous, large-scale studies to determine whether there is a causal relationship between acetaminophen exposure *in utero* and neurodevelopmental outcomes. Researchers will investigate potential mechanisms by which acetaminophen might affect fetal brain progress.
It is important to note that current medical consensus, as stated by the World Health Association (WHO), the American College of Obstetricians and Gynecologists (ACOG), and the american Academy of Pediatrics (AAP), does not indicate that acetaminophen causes neurodevelopmental issues. These organizations recommend limiting acetaminophen use during pregnancy to only when necessary, but do not advise against its use when medically indicated.